文献速递肝病消化道出血

在肝硬化患者的前瞻性非随机研究中,扩张不足的TIPS与疗效相关并减少肝性脑病

Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-03-03

这项前瞻性非随机研究在意大利转诊中心纳入42例接受扩张不足TIPS(7和6 mm)的肝硬化患者与53例接受8 mm或以上PTFE覆膜支架的对照,随访6个月,发现扩张不足TIPS组肝性脑病发生率显著低于对照组,而复发性静脉曲张出血或腹水无显著差异,无TIPS闭塞,验证队列结果一致。

要点

  • 扩张不足TIPS组肝性脑病发生率为27%,显著低于对照组的54%(P = .015)。
  • 两组复发性静脉曲张出血或腹水的比例无显著差异,且未观察到TIPS闭塞。
  • 在平均252天随访中,PTFE覆膜支架在血流动力学相关部位均未自膨胀至标称直径。

核心结论

  • 在肝硬化患者的前瞻性非随机研究中,TIPS置入时对PTFE覆膜支架进行扩张不足是可行的,与较低的肝性脑病发生率相关,且有效。

研究设计与样本

  • 前瞻性非随机研究在意大利转诊中心纳入42例接受扩张不足TIPS(7和6 mm)的未选择肝硬化患者与53例接受8 mm或以上PTFE覆膜支架的对照。
  • 研究完成后,扩张至6 mm成为标准,另纳入47例患者进入验证研究。
  • 所有患者随访6个月,TIPS置入后2周和3个月行多普勒超声,此后每6个月一次。
  • 通过计算机断层扫描分析226例肝硬化患者(支架增至6、7、8、9或10 mm)评估PTFE覆膜支架直径的稳定性。

主要发现

  • 术后第一年,扩张不足TIPS组肝性脑病(PSE)发生比例为27%,显著低于对照组的54%(P = .015)。
  • 两组复发性静脉曲张出血或腹水的比例无显著差异。
  • 未观察到TIPS闭塞,验证队列证实了上述结果。
  • 在置入后平均252天随访期间,PTFE覆膜支架在血流动力学相关部位(如门静脉和肝静脉血管壁)均未自膨胀至标称直径。

关键数值与推荐

  • 主要结局包括随访期间至少1次2级或以上PSE发作的发生率、复发性静脉曲张出血或腹水的发生率、需要TIPS再通的支架功能障碍发生率以及门腔压力梯度的降低。
  • 扩张不足TIPS组PSE发生率为27%,对照组为54%(P = .015)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Portosystemic encephalopathy (PSE) is a major complication of trans-jugular intrahepatic porto-systemic shunt (TIPS) placement. Most devices are self-expandable polytetrafluoroethylene-covered stent grafts (PTFE-SGs) that are dilated to their nominal diameter (8 or 10 mm). We investigated whether PTFE-SGs dilated to a smaller caliber (under-dilated TIPS) reduce PSE yet maintain clinical and hemodynamic efficacy. We also studied whether under-dilated TIPS self-expand to nominal diameter over time. METHODS: We performed a prospective, non-randomized study of 42 unselected patients with cirrhosis who received under-dilated TIPS (7 and 6 mm) and 53 patients who received PTFE-SGs of 8 mm or more (controls) at referral centers in Italy. After completion of this study, dilation to 6 mm became the standard and 47 patients were included in a validation study. All patients were followed for 6 months; Doppler ultrasonography was performed 2 weeks and 3 months after TIPS placement and every 6 months thereafter. Stability of PTFE-SG diameter was evaluated by computed tomography analysis of 226 patients with cirrhosis whose stent grafts increased to 6, 7, 8, 9, or 10 mm. The primary outcomes were incidence of at least 1 episode of PSE grade 2 or higher during follow up, incidence of recurrent variceal hemorrhage or ascites, incidence of shunt dysfunction requiring TIPS recanalization, and reduction in porto-caval pressure gradient. RESULTS: PSE developed in a significantly lower proportion of patients with under-dilated TIPS (27%) than controls (54%) during the first year after the procedure (P = .015), but the proportions of patients with recurrent variceal hemorrhage or ascites did not differ significantly between groups. No TIPS occlusions were observed. These results were confirmed in the validation cohort. In an analysis of self-expansion of stent grafts, during a mean follow-up period of 252 days after placement, none of the PTFE-SGs self-expanded to the nominal diameter in hemodynamically relevant sites (such as portal and hepatic vein vascular walls). CONCLUSIONS: In prospective, non-randomized study of patients with cirrhosis, we found under-dilation of PTFE-SGs during TIPS placement to be feasible, associated with lower rates of PSE, and effective.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Schepis F, Vizzutti F, Garcia-Tsao G, et al. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2018. PMID: 29378312. doi:10.1016/j.cgh.2018.01.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。